Sunder Biomedical Tech Co (ROCO:4115) ROCE %: 1.26% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4115 Sunder Biomedical Tech Co Ltd ROCO:4115
52 GF Score
Price NT$7.86
GF Value NT$10.70
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Sunder Biomedical Tech Co ROCE %?

Sunder Biomedical Tech Co ROCO:4115 +0.38% 52 ROCE % is 1.26% as of Dec. 2025. GuruFocus rates ROCO:4115 with a GF Score™ of 52/100 and a GF Value™ of NT$10.70 (Modestly Undervalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sunder Biomedical Tech Co's annualized ROCE % for the quarter that ended in Dec. 2025 was 1.26%.

Sunder Biomedical Tech Co  (ROCO:4115) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sunder Biomedical Tech Co ROCE % Related Terms

Sunder Biomedical Tech Co ROCE % Historical Data

* Premium members only.

The historical data trend for Sunder Biomedical Tech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunder Biomedical Tech Co ROCE % Chart

Sunder Biomedical Tech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial 9.33 2.18 -2.76 4.31 -1.77

Sunder Biomedical Tech Co Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.19 5.64 2.91 -4.85 1.26
ROCO:4115
52GF Score
Sunder Biomedical Tech Co Ltd ROCO:4115
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunder Biomedical Tech Co ROCE % Calculation

Sunder Biomedical Tech Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-16.305/( ( (1317.472 - 373.068) + (1273.666 - 372.755) )/ 2 )
=-16.305/( (944.404+900.911)/ 2 )
=-16.305/922.6575
=-1.77 %

Sunder Biomedical Tech Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=11.032/( ( (1205.613 - 350.968) + (1273.666 - 372.755) )/ 2 )
=11.032/( ( 854.645 + 900.911 )/ 2 )
=11.032/877.778
=1.26 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 1.26% mean?
Sunder Biomedical Tech Co (ROCO:4115) has a ROCE % of 1.26% as of Dec. 2025.
Is Sunder Biomedical Tech Co's ROCE % too high?
Sunder Biomedical Tech Co's current ROCE % is 1.26%. The Medical Devices & Instruments industry median ROCE % is 2.30. Sunder Biomedical Tech Co's value of 1.26% is 45.1% below this industry median. Overall, Sunder Biomedical Tech Co has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sunder Biomedical Tech Co's ROCE % compare to ISRG and BDX?
Sunder Biomedical Tech Co's ROCE % of 1.26% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.30. Sunder Biomedical Tech Co's value of 1.26% is 45.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.30, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunder Biomedical Tech Co's current ROCE % of 1.26% is 45.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunder Biomedical Tech Co's current ROCE % is 1.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunder Biomedical Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Sunder Biomedical Tech Co (ROCO:4115) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$10.70, compared to a current price of NT$7.86 — trading 26.5% below its estimated fair value. The current ROCE % is 1.26% and 45.1% below the Medical Devices & Instruments industry median of 2.30. Sunder Biomedical Tech Co's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Sunder Biomedical Tech Co (ROCO:4115), the current ROCE % is 1.26% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunder Biomedical Tech Co (ROCO:4115) Overvalued in 2026?

Based on GuruFocus' analysis, Sunder Biomedical Tech Co stock appears to be undervalued. The current stock price of NT$7.86 is trading 26.5% below its estimated GF Value™ of NT$10.70. GuruFocus considers Sunder Biomedical Tech Co to be Modestly Undervalued.

Key valuation signals for ROCO:4115:

  • ROCE %: 1.26%
  • GF Value™: NT$10.70 vs. price of NT$7.86 (26.5% below fair value)
  • GF Score™: 52/100 with 4 warning signs
  • Industry Position: 45.1% below the Medical Devices & Instruments median

No single metric tells the full story. See the ROCO:4115 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sunder Biomedical Tech Co Business Description

Address No. 1-67, Zhongzheng Road, Chung-Ming Village, Pao-Chung Hsiang, Yunlin, TWN, 63441
Sunder Biomedical Tech Co Ltd is engaged in providing medical devices. Its products include Protective Goggles; Meltblown Nonwoven Fabric/Mask; Suction Irrigation Set; Smoke Filter; Endo Bag; Blood Line Set for Hemodialysis and others.
52GF Score

Get the complete analysis for ROCO:4115

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$7.86
Price
NT$10.70
GF Value